GSK3 inhibitor enhances gemtuzumab ozogamicin‐induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance-Reference-Cited by-同舟云学术

GSK3 inhibitor enhances gemtuzumab ozogamicin‐induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance

Published:2022-12-12 Issue:1 Volume:4 Page:153-164
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Inase Aki¹²^ORCID,Maimaitili Yimamu²,Kimbara Shiro²,Mizutani Yu²,Miyata Yoshiharu¹²,Ohata Shinya²,Matsumoto Hisayuki³,Kitao Akihito²,Sakai Rina²,Kawaguchi Koji²⁴,Higashime Ako²,Nagao Shigeki²,Kurata Keiji²,Goto Hideaki²⁵,Kawamoto Shinichiro⁶,Yakushijin Kimikazu²^ORCID,Minami Hironobu²⁷,Matsuoka Hiroshi¹²^ORCID

Affiliation:

1. Division of Bioresource Research and Development Department of Social/Community Medicine and Health Science Kobe University Graduate School of Medicine Kobe Japan

2. Division of Medical Oncology and Hematology Department of Medicine Kobe University Graduate School of Medicine Kobe Japan

3. Department of Clinical Laboratory Kobe University Hospital Kobe Japan

4. Department of Medical Oncology/Hematology Konan Medical Center Kobe Japan

5. Department of Hematology and Oncology Kita‐harima Medical Center Ono Japan

6. Department of Transfusion and Cell Therapy Kobe University Hospital Kobe Japan

7. Cancer Center, Kobe University Hospital Kobe Japan

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

General Earth and Planetary Sciences